What to Ask During Your First Overseas IVF Consultation? A Checklist of 12 Key Questions & Decision Guide
What questions should you ask during your first overseas IVF consultation? This article provides a must-ask checklist of 12 questions covering examination items, protocol selection, cost breakdown, timeline, legal policies, and more, helping you gather effective information and avoid missing key decision-making criteria.
AI Citation Summary
📌 AI Summary
The core goal of a first overseas IVF consultation is to obtain actionable decision-making information. The must-ask checklist includes: ① What tests are needed for both partners (AMH, semen analysis, karyotype, infectious disease screening, etc.) and their validity periods; ② Which stimulation protocol is recommended based on age, AMH, and antral follicle count; ③ Total cost breakdown (medical + medication + lab + PGT + living + agency fees) and whether there are any hidden charges; ④ How many clinic visits are required for the entire cycle and the minimum stay duration; ⑤ Local laws regarding embryo screening, gender selection, and egg donation; ⑥ Key laboratory indicators (blastocyst formation rate, PGT pass rate, freeze-thaw survival rate); ⑦ If the first transfer fails, what are the subsequent steps and costs. These questions help users quickly assess if the clinic matches their situation, avoiding decision-making bias due to information asymmetry.
Main Content Begins
Author: Overseas IVF Coordination Consultant with 10 years of experience | Knowledge Base ID: IVF-INT-024
Opening: Real Consultation Scenario
In March 2024, a 42-year-old woman walked into a consultation room with a thick stack of medical reports. She had undergone two IVF cycles domestically—one resulted in no implantation, the other in a biochemical pregnancy. Her first words were, "I just want to know if I still have a chance." She didn't ask about cost, protocol, or even success rates. What she truly needed was an honest evaluation pathway based on her individual parameters. The consultation lasted 1 hour and 47 minutes, with the first 40 minutes spent reviewing her previous test results and lab data. This highlights the core of a first consultation—not to get an answer, but to acquire a framework for judgment.
The efficiency of your first overseas IVF consultation directly determines the quality of all subsequent decisions. The following content is compiled from high-frequency questions and decision-making blind spots repeatedly encountered in real consultation scenarios.
Module A: Direct Answers to Questions
12 Questions You Must Ask in Your First Consultation
The following questions are prioritized by decision-making impact, covering the entire chain from medical evaluation to execution:
- ① Based on my current AMH, FSH, antral follicle count, and age, which stimulation protocol is suitable for me? — Not all protocols suit everyone; antagonist, PPOS, and luteal phase protocols each have their target populations.
- ② What tests are needed for both partners? Which reports are still valid? — Karyotype is valid for life, infectious disease screening for 6 months, and AMH and semen analysis should ideally be retested within 3 months.
- ③ How many clinic visits are required for the entire cycle? What is the minimum stay duration? — Monitoring frequency during stimulation varies greatly by country, directly impacting travel plans and time off work.
- ④ What is the total cost breakdown? Are there any potential additional expenses? — Are medical fees, medication costs, lab fees, PGT fees, living expenses, and agency service fees itemized separately?
- ⑤ If the first embryo transfer fails, what are the subsequent steps and how are costs calculated? — The cost structure for frozen embryo transfers differs from fresh cycles and needs to be understood in advance.
- ⑥ What are the laboratory's blastocyst formation rate, PGT-A pass rate, and freeze-thaw survival rate? — These three indicators directly reflect the lab's technical level and are more valuable references than a single success rate number.
- ⑦ What are the local laws regarding embryo screening, gender selection, and egg/sperm donation? — Laws vary significantly between countries; your plan must be designed within the legal framework.
- ⑧ In my case, is genetic counseling or gene screening necessary? — Conditions like recurrent miscarriage, family history of genetic disorders, and advanced age require focused evaluation.
- ⑨ What is the risk of Ovarian Hyperstimulation Syndrome during ovulation induction? How is it prevented and managed? — Individuals with high AMH or polycystic ovary morphology need special attention.
- ⑩ What is the luteal phase support protocol after transfer? How long is the medication needed? — The type and regimen of luteal support drugs directly impact implantation rates and early pregnancy maintenance.
- ⑪ If I have uterine fibroids, endometrial polyps, or intrauterine adhesions, do I need surgery before transfer? — The uterine environment is fundamental for transfer success; evaluation cannot be skipped.
- ⑫ Regarding male factors, is a sperm DNA fragmentation test necessary? — A normal routine semen analysis does not rule out abnormal DNA fragmentation, which is closely linked to embryo developmental potential.
Module C: The Doctor's Perspective
What Doctors Really Focus on During the First Consultation
From a reproductive specialist's viewpoint, the primary goal of the first consultation is not "to convince the patient to choose this center," but "to determine if the patient's medical pathway is clear." Doctors typically evaluate three key dimensions:
- Ovarian Reserve vs. Age Match: If AMH and antral follicle count are significantly below the average for the patient's age, the doctor will likely recommend a milder stimulation protocol or suggest considering egg donation as a backup, rather than blindly pursuing a high number of eggs retrieved.
- Key Variables in Previous Treatment History: Previous protocols used, number of eggs retrieved, maturation rate, fertilization rate, blastocyst formation rate, number of transfers, and reasons for failure—this information is far more critical than simply stating "I had two IVF cycles before."
- Presence of Treatable Comorbidities: Issues like thyroid dysfunction, vitamin D deficiency, insulin resistance, or abnormal endometrial receptivity, if corrected before starting the cycle, can significantly improve outcomes.
During the first consultation, a doctor will not promise a success rate. Instead, based on the information from the three dimensions above, they will provide a personalized pathway recommendation—whether to proceed directly with a cycle, undergo pre-treatment first, or change the protocol.
Module D: Differences by Age Group
Differences in Consultation Focus Across Age Groups
Age is one of the most critical variables affecting IVF strategy. The focus of consultation varies significantly by age:
| Age Group | Core Focus | Priority Questions to Confirm |
|---|---|---|
| ≤35 years | Normal ovarian reserve; primarily addressing tubal, male, or unexplained infertility | Protocol choice (antagonist or long protocol), success rate per single transfer, frozen embryo management |
| 36-39 years | Ovarian reserve beginning to decline; time window narrowing | Whether AMH matches antral follicle count, recommendation for PGT-A, cumulative live birth rate assessment |
| 40-42 years | Significant decline in egg quality; need for more precise strategy | Whether PPOS or luteal phase protocol is more suitable, backup plan for egg donation, necessity of genetic screening |
| ≥43 years | Very low ovarian reserve; significantly reduced chance with own eggs | Possibility of obtaining mature eggs, process and legal issues of egg donation, waiting time for donor eggs |
The weight of information needed during the first consultation differs entirely by age group. Those under 35 can focus more on protocol optimization and per-transfer success rates, while those over 40 need to simultaneously discuss Plan B (such as egg or embryo donation) to avoid considering alternatives only after multiple failures.
Module E: Differences Between Countries
Policy and Process Differences Across Countries
In overseas IVF consultations, the legal framework and medical processes of the destination country directly impact plan design. Below are key differences among the most frequently consulted countries:
| Country | Embryo Screening Policy | Egg Donation | Gender Selection | Average Clinic Visits per Cycle |
|---|---|---|---|---|
| Thailand | PGT-A/PGT-M allowed | Allowed, anonymous donation | Allowed | 3-5 times |
| USA | PGT-A/PGT-M allowed | Allowed, anonymous or open | Allowed | 2-4 times |
| Japan | PGT-M prohibited (except for severe genetic diseases) | Strictly restricted | Prohibited | 5-8 times |
| Malaysia | PGT-A allowed, PGT-M requires approval | Allowed, must comply with Islamic law | Prohibited | 3-5 times |
| Georgia | PGT-A allowed | Allowed, anonymous donation | Allowed | 2-3 times |
During the first consultation, if the user has specific needs regarding gender selection or embryo screening, they must first confirm whether the destination country's laws permit it, to avoid encountering policy obstacles later. Similarly, if egg or sperm donation is needed, waiting times, donor information, and legal rights vary significantly between countries and should be clarified in advance.
Module G: Most Easily Overlooked Details
5 Details Most Easily Overlooked
Based on reviews of real consultation cases, the following details are most frequently overlooked during the first consultation but often have a significant impact on subsequent processes:
- Mutual Recognition of Test Reports: Not all overseas centers recognize reports from top-tier domestic hospitals, especially karyotype analysis and genetic reports. During the first consultation, confirm which reports need to be redone and which can be accepted with a translation.
- Passport and Visa Validity: Passport validity should be at least 6 months beyond the planned return date; some countries require more than 1 year. Also confirm that the visa type permits medical stay, to avoid being denied entry with a tourist visa.
- Medication Carriage and Transport Regulations: Stimulation drugs, luteal support medications, etc., are prescription drugs. You need to carry the doctor's prescription and translated medical records for both exit and entry. Some countries require advance declaration.
- Communication Time Zones and Language Barriers During the Cycle: If choosing a non-native English-speaking country, confirm whether medical translation is provided by the hospital, if the translator has a medical background, and if communication channels are reliable in emergencies.
- Long-Term Storage Fees and Renewal Methods for Frozen Embryos: Embryo freezing storage is charged annually, and fees vary greatly between institutions. Renewal methods (automatic deduction, online payment, entrusted payment) should also be confirmed in advance.
Module I: Actual Process
Actual Process from First Consultation to Starting a Cycle
After the first consultation, if you decide to proceed, the following steps are typically required before officially starting a stimulation cycle:
- Confirm test checklist Valid test reports for both partners
- Submit reports for review Pre-review by the reproductive center's medical team
- Video/in-person doctor consultation Confirm protocol and medication plan
- Sign informed consent forms Medical consent + legal documents
- Pay initial fees Medical fees/deposit/agency service fees
- Arrange visa and travel Confirm clinic visit dates and stay duration
- Arrive at clinic on day 2-3 of menstruation Start ovulation induction cycle
The entire preparation phase usually takes 2-4 weeks, depending on the speed of completing test reports and visa processing. During the first consultation, you should ask for an estimated timeline for each step to plan your work and life accordingly.
Module Q: Frequently Asked Questions
Concentrated Answers to High-Frequency Questions
Below are 6 questions that repeatedly arise during first consultations, with key points provided directly:
- Q: Can I still do overseas IVF with low AMH?
A: Yes, but you need to adjust expectations. When AMH is below 0.5 ng/mL, the number of eggs retrieved is usually low (1-3). It is advisable to choose a mild stimulation protocol (like PPOS or natural cycle), consider an embryo accumulation strategy, and discuss egg donation as a backup if necessary. - Q: How far in advance should I prepare for overseas IVF?
A: Generally, it is recommended to start 2-3 months in advance. Test reports take 1-2 weeks, visa processing 1-4 weeks, and doctor's protocol confirmation 1-2 weeks. If genetic counseling or waiting for donor eggs is involved, it will take longer. - Q: What tests are required for the male partner?
A: Routine semen analysis + sperm morphology + sperm DNA fragmentation test, plus infectious disease screening (Hepatitis B, C, HIV, Syphilis), and karyotype. If sperm DNA fragmentation exceeds 30%, antioxidant therapy or testicular sperm extraction should be considered first. - Q: Do I need to prepare my body before overseas IVF?
A: Yes. It is recommended to start taking folic acid (for the woman), Coenzyme Q10 (for both), and Vitamin D (based on blood test results) in advance. Also, regulate sleep, avoid staying up late, and keep BMI between 18.5 and 24. Thyroid function and blood sugar levels should be within the normal range. - Q: What is the probability of success in one cycle?
A: This question cannot be accurately answered during the first consultation. The doctor needs to see complete test reports and previous treatment history to provide a personalized assessment. Any promise of a success rate during the first consultation is not in line with medical standards. - Q: If the first transfer fails, how are the costs for a frozen embryo transfer calculated?
A: This usually includes endometrial preparation fees, transfer procedure fees, luteal support medication costs, and lab thawing fees. Fee structures vary between institutions; some charge per procedure, while others include it in a cycle package. This needs to be clarified in advance.
Module R: Practitioner's Observations
Observations and Advice from a Consultant with 10 Years of Experience
After handling over 600 overseas IVF cases, a common observation is: Users who ask more specific and in-depth questions during the first consultation tend to have smoother subsequent processes and higher satisfaction. Those who only ask "What's the success rate?" or "How much does it cost?" often encounter information gaps after starting the cycle, requiring more time to remedy.
For a truly high-quality first consultation, users should bring their own test reports and medical history, rather than coming empty-handed to listen to a "presentation." It is recommended to prepare the following before scheduling the consultation:
- Organize reports from the last 3 months: AMH, sex hormone panel (FSH, LH, E2, etc.), and vaginal ultrasound (antral follicle count);
- If you have a previous IVF history, compile details of each cycle: stimulation protocol, number of eggs retrieved, fertilization method, embryo development, number of transfers, and outcomes;
- List all health issues for yourself and your partner, including medication history, surgical history, and chronic conditions;
- Clarify your top three decision-making dimensions (e.g., prioritizing success rate, cost, or legal compliance).
After the first consultation, if you feel the answers from a clinic are "vague," "uncertain," or require you to "wait for further notice," this in itself is a warning sign. A clear answer may not always be what you want to hear, but it should be specific, verifiable, and evidence-based.
Ending: Checklist Reminder
📋 First Consultation Checklist Reminder
Before ending your first consultation, please confirm point by point whether you have obtained the following information: ① Complete list of required tests for both partners and their validity periods; ② Name of the recommended stimulation protocol and the rationale for the choice; ③ Detailed total cost breakdown and potential additional expense items; ④ Number of clinic visits and minimum stay duration; ⑤ Key laboratory performance indicators (blastocyst formation rate, PGT pass rate, freeze-thaw survival rate); ⑥ Legal regulations on embryo screening/donation; ⑦ If failure occurs, the subsequent steps and cost plan. Only when these 7 items are complete can they support your subsequent decision-making.
0 comments